We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




COVID-19 Infection Fatality Ratio is Close to One Percent

By HospiMedica International staff writers
Posted on 10 Nov 2020
Print article
A new report reveals that the COVID-19 infection fatality ratio (IFR) is 1.15% in high-income countries, but substantially lower in low-income countries with younger populations.

Researchers at Imperial College London (Imperial; United Kingdom) screened 175 studies to update estimates of COVID-19 IFR. Based on 10 representative antibody surveys, they found that age-specific IFRs followed a log-linear pattern, with the risk of death doubling approximately every eight years of age. They estimated that overall IFR in a typical low-income country, with a population structure skewed towards younger individuals, was 0.23%. In contrast, in a typical high income country, with a greater concentration of elderly individuals, the overall IFR was 1.15%.

Age-specific IFRs increased from 0.1% for those under 40 years to greater than 5% among individuals over 80 years. When accounting for seroreversion—the waning of antibodies leading to a negative serological result-- the IFR was slightly reduced among surveys conducted several months after the first wave of the outbreak, such as in Italy. In contrast, uncertainty in test false positive rates, combined with low serological prevalence in some surveys, reconciled apparently low crude fatality ratios with the IFR in other countries. The findings were published on October 29, 2020, by the MRC Centre for Global Infectious Disease Analysis.

“Although the elderly are by far at the highest risk of dying due to COVID-19, the risk in middle age is still high. For example, we estimate that around one in 260 people aged 50-55 years die if infected,” said senior author Lucy Okell, PhD. “We calculated COVID-19 fatality largely based on the first wave of the epidemic in a number of countries, and we hope and expect to see some reduction in fatality now due to new clinical knowledge and treatment, but this remains a dangerous virus.”

“We know that antibody tests are not perfect, and there may be a considerable number of people who do not mount a detectable antibody response to SARS-CoV-2,” said study co-author Robert Verity, PhD. “However, even when this uncertainty is taken into account, we still find that COVID-19 has a high fatality rate, on the order of one percent for a typical high-income country. This risk is concentrated in older ages, with the probability of dying from COVID-19 doubling approximately every eight years.”

IFR is a key statistic for estimating disease burden, representing the proportion of deaths among all infected individuals. Previous estimates have relied on data early in the COVID-19 epidemic, or have not fully accounted for uncertainty in serological test characteristics and delays from onset of infection to seroconversion, death, and antibody waning.

Related Links:
Imperial College London

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Patient Monitor
Vista 300
New
CPAP Machine
EcoStar Auto

Print article

Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.